Literature DB >> 28603323

Defining Cancer Subtypes With Distinctive Etiologic Profiles: An Application to the Epidemiology of Melanoma.

Audrey Mauguen1, Emily C Zabor1, Nancy E Thomas2,3, Marianne Berwick3, Venkatraman E Seshan1, Colin B Begg1.   

Abstract

We showcase a novel analytic strategy to identify sub-types of cancer that possess distinctive causal factors, i.e. sub-types that are "etiologically" distinct. The method involves the integrated analysis of two types of study design: an incident series of cases with double primary cancers with detailed information on tumor characteristics that can be used to define the sub-types; a case-series of incident cases with information on known risk factors that can be used to investigate the specific risk factors that distinguish the sub-types. The methods are applied to a rich melanoma dataset with detailed information on pathologic tumor factors, and comprehensive information on known genetic and environmental risk factors for melanoma. Identification of the optimal sub-typing solution is accomplished using a novel clustering analysis that seeks to maximize a measure that characterizes the distinctiveness of the distributions of risk factors across the sub-types and that is a function of the correlations of tumor factors in the case-specific tumor pairs. This analysis is challenged by the presence of extensive missing data. If successful, studies of this nature offer the opportunity for efficient study design to identify unknown risk factors whose effects are concentrated in defined sub-types.

Entities:  

Keywords:  case-control study; etiologic heterogeneity; k-means clustering; logistic regression; multiple imputation

Year:  2017        PMID: 28603323      PMCID: PMC5460661          DOI: 10.1080/01621459.2016.1191499

Source DB:  PubMed          Journal:  J Am Stat Assoc        ISSN: 0162-1459            Impact factor:   5.033


  24 in total

1.  Multiple imputation of discrete and continuous data by fully conditional specification.

Authors:  Stef van Buuren
Journal:  Stat Methods Med Res       Date:  2007-06       Impact factor: 3.021

2.  A prospective, population-based study of 40,000 women regarding host factors, UV exposure and sunbed use in relation to risk and anatomic site of cutaneous melanoma.

Authors:  Kari Nielsen; Anna Måsbäck; Håkan Olsson; Christian Ingvar
Journal:  Int J Cancer       Date:  2011-10-20       Impact factor: 7.396

3.  Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma.

Authors:  Nancy E Thomas; Sharon N Edmiston; Audrey Alexander; Pamela A Groben; Eloise Parrish; Anne Kricker; Bruce K Armstrong; Hoda Anton-Culver; Stephen B Gruber; Lynn From; Klaus J Busam; Honglin Hao; Irene Orlow; Peter A Kanetsky; Li Luo; Anne S Reiner; Susan Paine; Jill S Frank; Jennifer I Bramson; Lorraine D Marrett; Richard P Gallagher; Roberto Zanetti; Stefano Rosso; Terence Dwyer; Anne E Cust; David W Ollila; Colin B Begg; Marianne Berwick; Kathleen Conway
Journal:  JAMA Oncol       Date:  2015-06       Impact factor: 31.777

4.  Statistical analysis of molecular epidemiology studies employing case-series.

Authors:  C B Begg; Z F Zhang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1994-03       Impact factor: 4.254

5.  A comparison of the polytomous logistic regression and joint cox proportional hazards models for evaluating multiple disease subtypes in prospective cohort studies.

Authors:  Xiaonan Xue; Mimi Y Kim; Mia M Gaudet; Yikyung Park; Moonseong Heo; Albert R Hollenbeck; Howard D Strickler; Marc J Gunter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-01-04       Impact factor: 4.254

6.  Association between BRAFV600E and NRASQ61R mutations and clinicopathologic characteristics, risk factors and clinical outcome of primary invasive cutaneous melanoma.

Authors:  Shaowei Wu; Helen Kuo; Wen-Qing Li; Alvaro Laga Canales; Jiali Han; Abrar A Qureshi
Journal:  Cancer Causes Control       Date:  2014-07-22       Impact factor: 2.506

7.  Association of Interferon Regulatory Factor-4 Polymorphism rs12203592 With Divergent Melanoma Pathways.

Authors:  David C Gibbs; Irene Orlow; Jennifer I Bramson; Peter A Kanetsky; Li Luo; Anne Kricker; Bruce K Armstrong; Hoda Anton-Culver; Stephen B Gruber; Loraine D Marrett; Richard P Gallagher; Roberto Zanetti; Stefano Rosso; Terence Dwyer; Ajay Sharma; Emily La Pilla; Lynn From; Klaus J Busam; Anne E Cust; David W Ollila; Colin B Begg; Marianne Berwick; Nancy E Thomas
Journal:  J Natl Cancer Inst       Date:  2016-02-08       Impact factor: 13.506

8.  Risk factors for melanoma by body site.

Authors:  Eunyoung Cho; Bernard A Rosner; Graham A Colditz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-05       Impact factor: 4.254

9.  Number of nevi and early-life ambient UV exposure are associated with BRAF-mutant melanoma.

Authors:  Nancy E Thomas; Sharon N Edmiston; Audrey Alexander; Robert C Millikan; Pamela A Groben; Honglin Hao; Dawn Tolbert; Marianne Berwick; Klaus Busam; Colin B Begg; Dianne Mattingly; David W Ollila; Chiu Kit Tse; Amanda Hummer; Julia Lee-Taylor; Kathleen Conway
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-05       Impact factor: 4.254

10.  Combining estimates of interest in prognostic modelling studies after multiple imputation: current practice and guidelines.

Authors:  Andrea Marshall; Douglas G Altman; Roger L Holder; Patrick Royston
Journal:  BMC Med Res Methodol       Date:  2009-07-28       Impact factor: 4.615

View more
  3 in total

1.  Evidence for Etiologic Subtypes of Breast Cancer in the Carolina Breast Cancer Study.

Authors:  Halei C Benefield; Emily C Zabor; Yue Shan; Emma H Allott; Colin B Begg; Melissa A Troester
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-08-08       Impact factor: 4.254

2.  Family Study Designs Informed by Tumor Heterogeneity and Multi-Cancer Pleiotropies: The Power of the Utah Population Database.

Authors:  Heidi A Hanson; Claire L Leiser; Michael J Madsen; John Gardner; Stacey Knight; Melissa Cessna; Carol Sweeney; Jennifer A Doherty; Ken R Smith; Philip S Bernard; Nicola J Camp
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-02-25       Impact factor: 4.254

3.  Validity of a method for identifying disease subtypes that are etiologically heterogeneous.

Authors:  Emily C Zabor; Venkatraman E Seshan; Shuang Wang; Colin B Begg
Journal:  Stat Methods Med Res       Date:  2021-07-28       Impact factor: 2.494

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.